Lenzetto 1

DRUG2 trials

Sponsors

Amsterdam UMC, Oslo Universitetssykehus HF

Conditions

Long QT syndromeTransgender women using long-term gender-affirming hormone therapy

Phase 4

Short-term changes in cardiovascular risk determinants after temporarily stopping gender-affirming hormone therapy in older transgender women - a pilot study

CompletedCTIS2023-505143-39-00

Amsterdam UMCTransgender women using long-term gender-affirming hormone therapy

Start: 2024-02-23End: 2025-09-29Target: 30Updated: 2023-09-15

Effects of Menopausal Hormone Therapy on QTc in Genetically Confirmed Long QT Syndrome: A Prospective Randomized Sequential Crossover Study with Long-Term Observational Follow-Up (LQTS-HER)

Not yet recruitingCTIS2026-526442-28-00

Oslo Universitetssykehus HFLong QT syndrome

Target: 15Updated: 2026-08-20

Related Papers

Psychological and physical effects of short-term discontinuation of feminizing gender-affirming hormone therapy among older transgender women: a within-subject clinical trial.

2026-05-30